{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:07:23Z","timestamp":1778627243221,"version":"3.51.4"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010629","name":"Fulbright Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010629","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006501","name":"Cystic Fibrosis Foundation Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI112524"],"award-info":[{"award-number":["AI112524"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI093848"],"award-info":[{"award-number":["AI093848"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI095684"],"award-info":[{"award-number":["AI095684"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005565","name":"Janssen Biotech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.iac.2019.04.001","type":"journal-article","created":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T21:10:15Z","timestamp":1558473015000},"page":"321-334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Importance of Virus Characteristics in Respiratory Syncytial Virus-Induced Disease"],"prefix":"10.1016","volume":"39","author":[{"given":"Homero","family":"San-Juan-Vergara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark E.","family":"Peeples","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.iac.2019.04.001_bib1","first-page":"281","article-title":"Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). I. Isolation, properties and characterization","volume":"66","author":"Chanock","year":"1957","journal-title":"Am J Hyg"},{"issue":"4","key":"10.1016\/j.iac.2019.04.001_bib2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/oxfordjournals.aje.a120954","article-title":"An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine","volume":"89","author":"Kapikian","year":"1969","journal-title":"Am J Epidemiol"},{"issue":"Pt 12","key":"10.1016\/j.iac.2019.04.001_bib3","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1099\/0022-1317-82-12-2881","article-title":"Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine","volume":"82","author":"Prince","year":"2001","journal-title":"J\u00a0Gen Virol"},{"issue":"8","key":"10.1016\/j.iac.2019.04.001_bib4","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1128\/jvi.68.8.5321-5325.1994","article-title":"Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB\/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10","volume":"68","author":"Connors","year":"1994","journal-title":"J\u00a0Virol"},{"issue":"3 Pt 1","key":"10.1016\/j.iac.2019.04.001_bib5","first-page":"531","article-title":"Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group","volume":"102","author":"IMpact-RSV","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.iac.2019.04.001_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jpeds.2015.11.040","article-title":"Have changing palivizumab administration policies led to more respiratory morbidity in infants born at 32-35\u00a0weeks?","volume":"171","author":"Olicker","year":"2016","journal-title":"J\u00a0Pediatr"},{"issue":"4","key":"10.1016\/j.iac.2019.04.001_bib7","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1542\/peds.95.4.500","article-title":"Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls","volume":"95","author":"Sigurs","year":"1995","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.iac.2019.04.001_bib8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1006\/viro.2000.0293","article-title":"Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection","volume":"271","author":"Hallak","year":"2000","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.iac.2019.04.001_bib9","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/pro.5560060619","article-title":"Determination of the disulfide bond arrangement of human respiratory syncytial virus attachment (G) protein by matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry","volume":"6","author":"Gorman","year":"1997","journal-title":"Protein Sci"},{"key":"10.1016\/j.iac.2019.04.001_bib10","first-page":"83","article-title":"Structure and function of respiratory syncytial virus surface glycoproteins","volume":"372","author":"McLellan","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"issue":"11","key":"10.1016\/j.iac.2019.04.001_bib11","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1128\/JVI.76.11.5654-5666.2002","article-title":"Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology","volume":"76","author":"Zhang","year":"2002","journal-title":"J\u00a0Virol"},{"issue":"2","key":"10.1016\/j.iac.2019.04.001_bib12","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1128\/JVI.79.2.1113-1124.2005","article-title":"Infection of ciliated cells by human parainfluenza virus type 3 in an in\u00a0vitro model of human airway epithelium","volume":"79","author":"Zhang","year":"2005","journal-title":"J\u00a0Virol"},{"issue":"12","key":"10.1016\/j.iac.2019.04.001_bib13","doi-asserted-by":"crossref","first-page":"e1005318","DOI":"10.1371\/journal.ppat.1005318","article-title":"Respiratory syncytial virus uses CX3CR1 as a receptor on primary human airway epithelial cultures","volume":"11","author":"Johnson","year":"2015","journal-title":"PLoS Pathog"},{"issue":"8","key":"10.1016\/j.iac.2019.04.001_bib14","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/90675","article-title":"CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein","volume":"2","author":"Tripp","year":"2001","journal-title":"Nat Immunol"},{"issue":"9","key":"10.1016\/j.iac.2019.04.001_bib15","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1099\/vir.0.000218","article-title":"CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells","volume":"96","author":"Chirkova","year":"2015","journal-title":"J\u00a0Gen Virol"},{"issue":"6","key":"10.1016\/j.iac.2019.04.001_bib16","doi-asserted-by":"crossref","first-page":"e0130517","DOI":"10.1371\/journal.pone.0130517","article-title":"CX3CR1 is expressed in differentiated human ciliated airway cells and co-localizes with respiratory syncytial virus on cilia in a G protein-dependent manner","volume":"10","author":"Jeong","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.iac.2019.04.001_bib17","doi-asserted-by":"crossref","first-page":"e1006935","DOI":"10.1371\/journal.ppat.1006935","article-title":"Structural basis for recognition of the central conserved region of RSV G by neutralizing human antibodies","volume":"14","author":"Jones","year":"2018","journal-title":"PLoS Pathog"},{"issue":"2","key":"10.1016\/j.iac.2019.04.001_bib18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1286-4579(02)00079-5","article-title":"Isolation and characterisation of potential respiratory syncytial virus receptor(s) on epithelial cells","volume":"5","author":"Malhotra","year":"2003","journal-title":"Microbes Infect"},{"issue":"5","key":"10.1016\/j.iac.2019.04.001_bib19","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1165\/ajrcmb.23.5.3771","article-title":"Surfactant protein-A enhances uptake of respiratory syncytial virus by monocytes and U937 macrophages","volume":"23","author":"Barr","year":"2000","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"10.1016\/j.iac.2019.04.001_bib20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/vim.2000.13.125","article-title":"Lung surfactant protein A provides a route of entry for respiratory syncytial virus into host cells","volume":"13","author":"Hickling","year":"2000","journal-title":"Viral Immunol"},{"issue":"7","key":"10.1016\/j.iac.2019.04.001_bib21","doi-asserted-by":"crossref","first-page":"e1005035","DOI":"10.1371\/journal.ppat.1005035","article-title":"Characterization of a prefusion-specific antibody that recognizes a quaternary, cleavage-dependent epitope on the RSV fusion glycoprotein","volume":"11","author":"Gilman","year":"2015","journal-title":"PLoS Pathog"},{"issue":"27","key":"10.1016\/j.iac.2019.04.001_bib22","doi-asserted-by":"crossref","first-page":"11133","DOI":"10.1073\/pnas.1309070110","article-title":"Architecture of respiratory syncytial virus revealed by electron cryotomography","volume":"110","author":"Liljeroos","year":"2013","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"9","key":"10.1016\/j.iac.2019.04.001_bib23","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/nm.2444","article-title":"Identification of nucleolin as a cellular receptor for human respiratory syncytial virus","volume":"17","author":"Tayyari","year":"2011","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.iac.2019.04.001_bib24","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1006\/bbrc.2000.4093","article-title":"Blocking intercellular adhesion molecule-1 on human epithelial cells decreases respiratory syncytial virus infection","volume":"280","author":"Behera","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.iac.2019.04.001_bib25","doi-asserted-by":"crossref","first-page":"e1005622","DOI":"10.1371\/journal.ppat.1005622","article-title":"EGFR Interacts with the fusion protein of respiratory syncytial virus strain 2-20 and mediates infection and mucin expression","volume":"12","author":"Currier","year":"2016","journal-title":"PLoS Pathog"},{"issue":"6","key":"10.1016\/j.iac.2019.04.001_bib26","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1242\/jcs.198853","article-title":"Caveolae provide a specialized membrane environment for respiratory syncytial virus assembly","volume":"130","author":"Ludwig","year":"2017","journal-title":"J\u00a0Cell Sci"},{"issue":"3","key":"10.1016\/j.iac.2019.04.001_bib27","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1128\/JVI.06274-11","article-title":"Cholesterol-rich microdomains as docking platforms for respiratory syncytial virus in normal human bronchial epithelial cells","volume":"86","author":"San-Juan-Vergara","year":"2012","journal-title":"J\u00a0Virol"},{"issue":"12","key":"10.1016\/j.iac.2019.04.001_bib28","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s00894-016-3150-6","article-title":"Structure and functional dynamics characterization of the ion channel of the human respiratory syncytial virus (hRSV) small hydrophobic protein (SH) transmembrane domain by combining molecular dynamics with excited normal modes","volume":"22","author":"Araujo","year":"2016","journal-title":"J\u00a0Mol Model"},{"issue":"20","key":"10.1016\/j.iac.2019.04.001_bib29","doi-asserted-by":"crossref","first-page":"11899","DOI":"10.1128\/JVI.00839-14","article-title":"Inhibition of the human respiratory syncytial virus small hydrophobic protein and structural variations in a bicelle environment","volume":"88","author":"Li","year":"2014","journal-title":"J\u00a0Virol"},{"issue":"2","key":"10.1016\/j.iac.2019.04.001_bib30","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1006\/viro.1994.1245","article-title":"Analysis of respiratory syncytial virus F, G, and SH proteins in cell fusion","volume":"200","author":"Heminway","year":"1994","journal-title":"Virology"},{"issue":"15","key":"10.1016\/j.iac.2019.04.001_bib31","doi-asserted-by":"crossref","first-page":"8361","DOI":"10.1128\/JVI.02717-06","article-title":"Function of the respiratory syncytial virus small hydrophobic protein","volume":"81","author":"Fuentes","year":"2007","journal-title":"J\u00a0Virol"},{"issue":"5","key":"10.1016\/j.iac.2019.04.001_bib32","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1074\/mcp.M111.015909","article-title":"The human respiratory syncytial virus nonstructural protein 1 regulates type I and type II interferon pathways","volume":"11","author":"Hastie","year":"2012","journal-title":"Mol Cell Proteomics"},{"issue":"12","key":"10.1016\/j.iac.2019.04.001_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/v10120716","article-title":"Human respiratory syncytial virus NS 1 targets TRIM25 to suppress RIG-I ubiquitination and subsequent RIG-I-mediated antiviral signaling","volume":"10","author":"Ban","year":"2018","journal-title":"Viruses"},{"issue":"8","key":"10.1016\/j.iac.2019.04.001_bib34","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1128\/JVI.02434-08","article-title":"Human respiratory syncytial virus nonstructural protein NS2 antagonizes the activation of beta interferon transcription by interacting with RIG-I","volume":"83","author":"Ling","year":"2009","journal-title":"J\u00a0Virol"},{"issue":"Pt 9","key":"10.1016\/j.iac.2019.04.001_bib35","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1099\/vir.0.032987-0","article-title":"A\u00a0novel mechanism for the inhibition of interferon regulatory factor-3-dependent gene expression by human respiratory syncytial virus NS1 protein","volume":"92","author":"Ren","year":"2011","journal-title":"J\u00a0Gen Virol"},{"issue":"9","key":"10.1016\/j.iac.2019.04.001_bib36","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1128\/JVI.79.9.5353-5362.2005","article-title":"Effects of nonstructural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF-kappaB, and proinflammatory cytokines","volume":"79","author":"Spann","year":"2005","journal-title":"J\u00a0Virol"},{"issue":"3","key":"10.1016\/j.iac.2019.04.001_bib37","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.micinf.2012.11.012","article-title":"Advances in understanding respiratory syncytial virus infection in airway epithelial cells and consequential effects on the immune response","volume":"15","author":"Lay","year":"2013","journal-title":"Microbes Infect"},{"issue":"4","key":"10.1016\/j.iac.2019.04.001_bib38","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1099\/jgv.0.001040","article-title":"Role of p53\/NF-kappaB functional balance in respiratory syncytial virus-induced inflammation response","volume":"99","author":"Machado","year":"2018","journal-title":"J\u00a0Gen Virol"},{"issue":"10","key":"10.1016\/j.iac.2019.04.001_bib39","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.intimp.2008.03.012","article-title":"Host immunity during RSV pathogenesis","volume":"8","author":"Bueno","year":"2008","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"10.1016\/j.iac.2019.04.001_bib40","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/00006454-199311000-00007","article-title":"Detection of alpha-interferon in nasopharyngeal secretions and sera in children infected with respiratory syncytial virus","volume":"12","author":"Nakayama","year":"1993","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.iac.2019.04.001_bib41","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.vaccine.2013.11.013","article-title":"Synergistic induction of interferon alpha through TLR-3 and TLR-9 agonists stimulates immune responses against measles virus in neonatal cotton rats","volume":"32","author":"Kim","year":"2014","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.iac.2019.04.001_bib42","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1016\/j.vaccine.2012.09.043","article-title":"The status of live viral vaccination in early life","volume":"31","author":"Gans","year":"2013","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.iac.2019.04.001_bib43","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.cell.2006.02.019","article-title":"Translating innate immunity into immunological memory: implications for vaccine development","volume":"124","author":"Pulendran","year":"2006","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.iac.2019.04.001_bib44","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ni.2039","article-title":"Immunological mechanisms of vaccination","volume":"12","author":"Pulendran","year":"2011","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.iac.2019.04.001_bib45","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/icb.2012.7","article-title":"Modulation of T-cell function by type I interferon","volume":"90","author":"Tough","year":"2012","journal-title":"Immunol Cell Biol"},{"issue":"2","key":"10.1016\/j.iac.2019.04.001_bib46","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2174\/187152612800100116","article-title":"Respiratory syncytial virus infection in adult populations","volume":"12","author":"Walsh","year":"2012","journal-title":"Infect Disord Drug Targets"},{"issue":"5","key":"10.1016\/j.iac.2019.04.001_bib47","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1172\/JCI72948","article-title":"RSV-encoded NS2 promotes epithelial cell shedding and distal airway obstruction","volume":"124","author":"Liesman","year":"2014","journal-title":"J\u00a0Clin Invest"},{"issue":"3","key":"10.1016\/j.iac.2019.04.001_bib48","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jaci.2014.05.049","article-title":"Epithelial barrier function: at the front line of asthma immunology and allergic airway inflammation","volume":"134","author":"Georas","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"15","key":"10.1016\/j.iac.2019.04.001_bib49","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00621-18","article-title":"Five residues in the apical loop of the respiratory syncytial virus fusion protein F2 subunit are critical for its fusion activity","volume":"92","author":"Hicks","year":"2018","journal-title":"J\u00a0Virol"},{"issue":"6136","key":"10.1016\/j.iac.2019.04.001_bib50","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1126\/science.1234914","article-title":"Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody","volume":"340","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.iac.2019.04.001_bib51","doi-asserted-by":"crossref","first-page":"10224","DOI":"10.1038\/ncomms10224","article-title":"RSV-specific airway resident memory CD8+ T\u00a0cells and differential disease severity after experimental human infection","volume":"6","author":"Jozwik","year":"2015","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.iac.2019.04.001_bib52","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/cei.12720","article-title":"Respiratory syncytial virus induces phosphorylation of mTOR at ser2448 in CD8 T\u00a0cells from nasal washes of infected infants","volume":"183","author":"de Souza","year":"2016","journal-title":"Clin Exp Immunol"},{"issue":"309","key":"10.1016\/j.iac.2019.04.001_bib53","doi-asserted-by":"crossref","first-page":"309ra162","DOI":"10.1126\/scitranslmed.aac4241","article-title":"Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera","volume":"7","author":"Ngwuta","year":"2015","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.iac.2019.04.001_bib54","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/infdis\/jix543","article-title":"Respiratory syncytial virus genotypes, host immune profiles, and disease severity in young children hospitalized with bronchiolitis","volume":"217","author":"Rodriguez-Fernandez","year":"2017","journal-title":"J\u00a0Infect Dis"},{"issue":"4","key":"10.1016\/j.iac.2019.04.001_bib55","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/infdis\/jiy496","article-title":"How respiratory syncytial virus genotypes influence the clinical course in infants hospitalized for bronchiolitis","volume":"219","author":"Midulla","year":"2019","journal-title":"J\u00a0Infect Dis"},{"issue":"16","key":"10.1016\/j.iac.2019.04.001_bib56","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1128\/JVI.01045-15","article-title":"Functional analysis of the 60-nucleotide duplication in the respiratory syncytial virus buenos aires strain attachment glycoprotein","volume":"89","author":"Hotard","year":"2015","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.iac.2019.04.001_bib57","series-title":"Respiratory syncytial virus uses CX3CR1 as a cellular receptor on primary human airway epithelial cultures [Dissertation]","author":"Johnson","year":"2015"},{"issue":"21","key":"10.1016\/j.iac.2019.04.001_bib58","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aar3534","article-title":"Structures of respiratory syncytial virus G antigen bound to broadly neutralizing antibodies","volume":"3","author":"Fedechkin","year":"2018","journal-title":"Sci Immunol"},{"issue":"15","key":"10.1016\/j.iac.2019.04.001_bib59","doi-asserted-by":"crossref","first-page":"7788","DOI":"10.1128\/JVI.00555-11","article-title":"Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopes","volume":"85","author":"McLellan","year":"2011","journal-title":"J\u00a0Virol"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856119300256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856119300256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:07:18Z","timestamp":1778623638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856119300256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0889856119300256"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2019.04.001","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Importance of Virus Characteristics in Respiratory Syncytial Virus-Induced Disease","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2019.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}